Cargando…
Use of biomarkers for assessing radiation injury and efficacy of countermeasures
Several candidate drugs for acute radiation syndrome (ARS) have been identified that have low toxicity and significant radioprotective and radiomitigative efficacy. Inasmuch as exposing healthy human volunteers to injurious levels of radiation is unethical, development and approval of new radiation...
Autores principales: | Singh, Vijay K, Newman, Victoria L, Romaine, Patricia LP, Hauer-Jensen, Martin, Pollard, Harvey B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732464/ https://www.ncbi.nlm.nih.gov/pubmed/26568096 http://dx.doi.org/10.1586/14737159.2016.1121102 |
Ejemplares similares
-
Biologics as countermeasures for acute radiation syndrome: where are we now?
por: Singh, Vijay K, et al.
Publicado: (2015) -
Radiation countermeasure agents: an update (2011 – 2014)
por: Singh, Vijay K, et al.
Publicado: (2014) -
Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents
por: Singh, Vijay K., et al.
Publicado: (2016) -
Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile
por: Singh, Vijay K., et al.
Publicado: (2015) -
Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure
por: Singh, Vijay K., et al.
Publicado: (2016)